Medtronic plc (Dublin, Ireland) introduced the MiniMed Mio Advance infusion set to all Medtronic insulin pump customers in the U.S. The MiniMed Mio Advance infusion set is the newest addition to the MiniMed portfolio of infusion sets and gives people using insulin pumps an optimal user experience with fewer steps. The MiniMed Mio Advance infusion set is inserted in only … [Read more...]
Abbott, Tandem Diabetes Care partner to integrate tech for automated insulin delivery systems
Abbott (Abbott Park, IL) and Tandem Diabetes Care have finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's continuous glucose monitoring (CGM) technology with Tandem's insulin delivery systems to provide more options for people to manage their diabetes. The companies first announced their intention to work together in … [Read more...]
Medtronic shares study results on extended wear infusion set from American Diabetes Association Conference
Medtronic plc (Dublin, Ireland) announced data on its extended wear infusion set presented at the virtual 80th Scientific Sessions of the American Diabetes Association (ADA). The research revealed that Medtronic Extended infusion sets last twice as long as standard infusion sets, which must be changed every two to three days. According to the company, it is the only … [Read more...]
Abbott’s FreeStyle Libre 2 ICGM cleared in U.S. for adults, children with diabetes
Abbott (Abbott Park, IL) announced that the U.S. Food and Drug Administration (FDA) cleared its next-generation FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system for adults and children ages 4 and older with diabetes. According to the company, this is the only iCGM system with optional real-time alarms that measures glucose levels every minute, … [Read more...]
Oral medication for Type 2 diabetes approved
Patients have a new oral option to treat their Type 2 diabetes. Rybelsus (semaglutide) is the first glucagon-like peptide (GLP-1) receptor protein treatment approved for use in the United States that does not need to be injected. The approval of Rybelsus was granted to Novo Nordisk in September. Until now, GLP-1s have only been available as injectables, said Louis H. … [Read more...]